These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35785592)

  • 1. Kidney organoid research: current status and applications.
    Trush O; Takasato M
    Curr Opin Genet Dev; 2022 Aug; 75():101944. PubMed ID: 35785592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Utility of Human Kidney Organoids in Modeling Kidney Disease.
    Przepiorski A; Crunk AE; Espiritu EB; Hukriede NA; Davidson AJ
    Semin Nephrol; 2020 Mar; 40(2):188-198. PubMed ID: 32303281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell-derived kidney cells and organoids: Recent breakthroughs and emerging applications.
    Chuah JKC; Zink D
    Biotechnol Adv; 2017; 35(2):150-167. PubMed ID: 28017905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney organoids in translational medicine: Disease modeling and regenerative medicine.
    Miyoshi T; Hiratsuka K; Saiz EG; Morizane R
    Dev Dyn; 2020 Jan; 249(1):34-45. PubMed ID: 30843293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.
    Zhu L; Liu K; Feng Q; Liao Y
    Stem Cell Rev Rep; 2022 Dec; 18(8):2593-2605. PubMed ID: 35525908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine.
    Lee H; Son MY
    Int J Stem Cells; 2021 Feb; 14(1):9-20. PubMed ID: 33632980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases.
    Grassi L; Alfonsi R; Francescangeli F; Signore M; De Angelis ML; Addario A; Costantini M; Flex E; Ciolfi A; Pizzi S; Bruselles A; Pallocca M; Simone G; Haoui M; Falchi M; Milella M; Sentinelli S; Di Matteo P; Stellacci E; Gallucci M; Muto G; Tartaglia M; De Maria R; Bonci D
    Cell Death Dis; 2019 Feb; 10(3):201. PubMed ID: 30814510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling.
    Miranda CC; Fernandes TG; Diogo MM; Cabral JMS
    Adv Biochem Eng Biotechnol; 2020; 171():189-224. PubMed ID: 31740987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interdisciplinary approaches to brain organoid biology].
    Kodera T; Osakada F
    Nihon Yakurigaku Zasshi; 2023; 158(1):64-70. PubMed ID: 36596494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoids for Drug Discovery and Personalized Medicine.
    Takahashi T
    Annu Rev Pharmacol Toxicol; 2019 Jan; 59():447-462. PubMed ID: 30113875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Central Nervous System Organoids: A Focus on Organoid-Based Models for Motor Neuron Disease.
    Vieira de Sá R; Cañizares Luna M; Pasterkamp RJ
    Tissue Eng Part C Methods; 2021 Mar; 27(3):213-224. PubMed ID: 33446055
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    van den Berg CW; Koudijs A; Ritsma L; Rabelink TJ
    J Am Soc Nephrol; 2020 May; 31(5):921-929. PubMed ID: 32354986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From organoids to transplantable artificial kidneys.
    Naganuma H; Nishinakamura R
    Transpl Int; 2019 Jun; 32(6):563-570. PubMed ID: 30710378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D kidney organoids for bench-to-bedside translation.
    Gupta N; Dilmen E; Morizane R
    J Mol Med (Berl); 2021 Apr; 99(4):477-487. PubMed ID: 33034708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney Organoids: A Translational Journey.
    Morizane R; Bonventre JV
    Trends Mol Med; 2017 Mar; 23(3):246-263. PubMed ID: 28188103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing liver organoids from induced pluripotent stem cells (iPSCs): An alternative source of organoid generation for liver cancer research.
    Nguyen R; Da Won Bae S; Qiao L; George J
    Cancer Lett; 2021 Jun; 508():13-17. PubMed ID: 33771683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creating a kidney organoid-vasculature interaction model using a novel organ-on-chip system.
    Bas-Cristóbal Menéndez A; Du Z; van den Bosch TPP; Othman A; Gaio N; Silvestri C; Quirós W; Lin H; Korevaar S; Merino A; Mulder J; Hoogduijn MJ
    Sci Rep; 2022 Nov; 12(1):20699. PubMed ID: 36450835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.